Biosimilar Drugs 

Journal Title: Journal of Clinical and Analytical Medicine - Year 2012, Vol 3, Issue 2

Abstract

Biotechnological (biopharmaceutical) products are complex macromolecules created through the genetic manipulation of living organisms using recombinant DNA technology, monocolonal antibodies and gene therapy. The patent expirations for many biotechnological medicines have prompted the development of copies of biological medicinal products. These new biotechnology medicines are known as “biosimilars”. Due to the complex method of production of biological medicines, biosimilar medicines are only similar in composition to a reference product, but may not be identical. Comparative quality, pre-clinical and clinical studies have to be provided by the biosimilar manufacturer to substantiate the similarity of structure/composition, quality, safety and efficacy between the new biosimilar and the chosen reference medicinal product. With a suitable regulatory process, biosimilars have the potential to provide considerable cost savings to both patients and healthcare providers. But, a comprehensive understanding of new products, including manufacturing process, prescribing habits, marketing practices, patent terms, and clinical use needs to be addressed with regulatory authorities, scientists and pharmaceutical industry before the future of biosimilars becomes a reality. 

Authors and Affiliations

Muradiye Nacak, Zafer Sezer, Aydın Erenmemişoğlu

Keywords

Related Articles

Soliter Böbrekte Unutulmuş Üreteral Stentli Olguda Travma Sonrası Retroperitoneal Hematom 

Üreteral stentler üroloji pratiğinde sık kullanılmaktadırlar. Unutulan üreteral stentlere bağlı olarak şiddetli enkrustasyonlar, büyük taş oluşumu, tekrarlayan üriner sistem enfeksiyonları, hematüri ve böbrek fonksiyon...

Astımlı Çocukların Yaşam Kalitelerinin Değerlendirilmesi 

Amaç: Bronşiyal astım, fiziksel, duygusal ve sosyal yönlerden hastanın yaşamında değişik oranlarda kısıtlamalara yol açabilen, en yaygın kronik çocukluk hastalıkları arasındadır. Bu çalışmanın amacı astmatik çocuklarda...

Postcoital Transvaginal Evisceration After Hysterectomy: A Case Report

Transvaginal evisceration is mostly seen at postmenopausal period in a case who had vaginal operation and at premenopausal period it ensues postcoitally after hysterectomy. A 47 year old patient presented to emergency...

Çocuk Tibia Şaft Kırıklarında Ender Çivisi Uygulamalarımız 

Amaç: Çocuklarda tibia şaft kırıkları çoğunlukla konservatif olarak tedavi edilmekle birlikte çoklu uzun kemik kırığı veya eşlik eden organ yaralanması olan ya da okul çağında olan tibia şaft kırıklı hastalarda cerrahi...

The Effects of 0.3 mA and 0.5 mA Threshold Currents on Axillary Brachial Plexus Block 

Aim The nerve block success by peripheral nerve stimulator may be increased by optimal nerve localization. However, it is not clear which current threshold is more suitable for this. Material and Methods Forty patie...

Download PDF file
  • EP ID EP130000
  • DOI 10.4328/JCAM.882
  • Views 131
  • Downloads 0

How To Cite

Muradiye Nacak, Zafer Sezer, Aydın Erenmemişoğlu (2012). Biosimilar Drugs . Journal of Clinical and Analytical Medicine, 3(2), 251-256. https://europub.co.uk./articles/-A-130000